Evidence map›Paper›PMID 32529267›Full record

ArticleActa neuropathologica2020

HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis.

Gayatri Devraj, Sylvaine Guérit, Jana Seele, Daniel Spitzer, Jadranka Macas, Maryam I Khel, Roxana Heidemann, Anne K Braczynski, Wibke Ballhorn, Stefan Günther and 9 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biological puzzles solved by usingJournal of bacteriology · 2024
    Review
  11. Article
  12. Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models.International journal of molecular sciences · 2023
    Review
  13. Roxadustat: Do we know all the answers?Biomolecules & biomedicine · 2023
    Review
  14. Article
  15. Review
  16. The neurovasculature as a target in temporal lobe epilepsy.Brain pathology (Zurich, Switzerland) · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Gayatri DevrajInstitute for Medical Microbiology and Infection Control, Goethe University, Frankfurt am Main, Germany.
Sylvaine GuéritEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Jana SeeleInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Daniel SpitzerEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Jadranka MacasEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Maryam I KhelEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Roxana HeidemannInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Anne K BraczynskiEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Wibke BallhornInstitute for Medical Microbiology and Infection Control, Goethe University, Frankfurt am Main, Germany.
Stefan GüntherMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Omolara O OgunsholaInstitute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.
Michel MittelbronnEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Uwe KödelDepartment of Neurology, Ludwig-Maximilians University, Munich, Germany.
Camelia M MonoranuDepartment of Neuropathology, Institute of Pathology, Julius Maximilians University, Würzburg, Germany.
Karl H PlateEdinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany.
Sven HammerschmidtDepartment of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, Greifswald, Germany.
Roland NauInstitute of Neuropathology, University Medical Center, Göttingen, Germany.
Kavi Devraj *Edinger Institute/Neurological Institute, Goethe University, Frankfurt am Main, Germany. Kavi.Devraj@kgu.de.
Volkhard A J Kempf *Institute for Medical Microbiology and Infection Control, Goethe University, Frankfurt am Main, Germany. volkhard.kempf@kgu.de.ORCID http://orcid.org/0000-0002-3321-7551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial meningitis is a deadly disease most commonly caused by Streptococcus pneumoniae, leading to severe neurological sequelae including cerebral edema, seizures, stroke, and mortality when untreated. Meningitis is initiated by the transfer of S. pneumoniae from blood to the brain across the blood-cerebrospinal fluid barrier or the blood-brain barrier (BBB). The underlying mechanisms are still poorly understood. Current treatment strategies include adjuvant dexamethasone for inflammation and cerebral edema, followed by antibiotics. The success of dexamethasone is however inconclusive, necessitating new therapies for controlling edema, the primary reason for neurological complications. Since we have previously shown a general activation of hypoxia inducible factor (HIF-1α) in bacterial infections, we hypothesized that HIF-1α, via induction of vascular endothelial growth factor (VEGF) is involved in transmigration of pathogens across the BBB. In human, murine meningitis brain samples, HIF-1α activation was observed by immunohistochemistry. S. pneumoniae infection in brain endothelial cells (EC) resulted in in vitro upregulation of HIF-1α/VEGF (Western blotting/qRT-PCR) associated with increased paracellular permeability (fluorometry, impedance measurements). This was supported by bacterial localization at cell-cell junctions in vitro and in vivo in brain ECs from mouse and humans (confocal, super-resolution, electron microscopy, live-cell imaging). Hematogenously infected mice showed increased permeability, S. pneumoniae deposition in the brain, along with upregulation of genes in the HIF-1α/VEGF pathway (RNA sequencing of brain microvessels). Inhibition of HIF-1α with echinomycin, siRNA in bEnd5 cells or using primary brain ECs from HIF-1α knock-out mice revealed reduced endothelial permeability and transmigration of S. pneumoniae. Therapeutic rescue using the HIF-1α inhibitor echinomycin resulted in increased survival and improvement of BBB function in S. pneumoniae-infected mice. We thus demonstrate paracellular migration of bacteria across BBB and a critical role for HIF-1α/VEGF therein and hence propose targeting this pathway to prevent BBB dysfunction and ensuing brain damage in infections.

Indexed as

Blood-Brain BarrierMeningitis, PneumococcalStreptococcus pneumoniaeAdultAgedAged, 80 and overAnimalsFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiceMice, Inbred C57BLMiddle AgedTransendothelial and Transepithelial MigrationVascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor ABlood–brain barrier (BBB)DexamethasoneEndotheliumHIF-1αMeningitisParacellular transmigrationPermeabilityS. pneumoniaeVEGF

Identifiers

PMID32529267
PMCPMC7360668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.